We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-0.35%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$469M
Cap. Flow
+$491M
Cap. Flow %
30.91%
Top 10 Hldgs %
26.26%
Holding
2,828
New
215
Increased
1,024
Reduced
629
Closed
413
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPFI icon
2726
South Plains Financial
SPFI
$840M
-22
Closed -$747
SPNT icon
2727
SiriusPoint
SPNT
$2.75B
-118
Closed -$1.69K
SPRY icon
2728
ARS Pharmaceuticals
SPRY
$542M
-22
Closed -$319
SRG
2729
Seritage Growth Properties
SRG
$137M
-7
Closed -$33
SRI icon
2730
Stoneridge
SRI
$210M
-23
Closed -$258
SSBK
2731
DELISTED
Southern States Bancshares
SSBK
-28
Closed -$861
SST icon
2732
System1
SST
$14.5M
-6
Closed -$71
STHO icon
2733
Star Holdings Shares of Beneficial Interest
STHO
$112M
-296
Closed -$4.1K
STRO icon
2734
Sutro Biopharma
STRO
$416M
-66
Closed -$2.27K
STVN icon
2735
Stevanato
STVN
$5.62B
-696
Closed -$13.9K
SVV icon
2736
Savers
SVV
$1.64B
-194
Closed -$2.04K
TAK icon
2737
Takeda Pharmaceutical
TAK
$53.7B
-1,556
Closed -$22.1K
TAN icon
2738
Invesco Solar ETF
TAN
$1.45B
-285
Closed -$12.3K
TBPH icon
2739
Theravance Biopharma
TBPH
$874M
-57
Closed -$460
TDUP icon
2740
ThredUp
TDUP
$801M
-107
Closed -$91
TELA icon
2741
TELA Bio
TELA
$33.1M
-60
Closed -$152
THRM icon
2742
Gentherm
THRM
$1.28B
-144
Closed -$6.7K
THRY icon
2743
Thryv Holdings
THRY
$189M
-274
Closed -$4.72K
TK icon
2744
Teekay
TK
$1.03B
-483
Closed -$4.44K
TNYA icon
2745
Tenaya Therapeutics
TNYA
$158M
-105
Closed -$203
TPIC
2746
DELISTED
TPI Composites
TPIC
-367
Closed -$1.67K
TRDA icon
2747
Entrada Therapeutics
TRDA
$282M
-45
Closed -$720
TTGT icon
2748
TechTarget
TTGT
$323M
-27
Closed -$661
TYRA icon
2749
Tyra Biosciences
TYRA
$1.91B
-7
Closed -$165
UHG
2750
DELISTED
United Homes Group
UHG
-117
Closed -$719

Similar funds

Arax Advisory Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Arax Advisory Partners held 2,828 positions worth $1.59B, up 42% from $1.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners deployed $491M of net new capital in Q4 2024, opening 215 new positions and adding to 1,024 existing holdings. Its largest new stake was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, up from 5.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Mid-Cap Value ETF, an estimated $3.07M trimmed.

  • Arax Advisory Partners's largest Q4 2024 buy was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.
  • Arax Advisory Partners added most to Vanguard Morningstar Growth ETF in Q4 2024, an estimated $33.3M increase.
  • Arax Advisory Partners's biggest Q4 2024 reduction was Vanguard Morningstar Mid-Cap Value ETF, cutting an estimated $3.07M.
  • Arax Advisory Partners fully exited WillScot Mobile Mini Holdings in Q4 2024, selling an estimated $508K.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.59B portfolio in Q4 2024.
  • Arax Advisory Partners opened 215 new positions and closed 413 in Q4 2024.
  • Arax Advisory Partners's portfolio value rose 42% quarter-over-quarter to $1.59B.

Based on Arax Advisory Partners's 13F filing for Q4 2024, filed 5 Feb 2025.